GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (CHIX:BIMp) » Definitions » Other Gross PPE

BioMerieux (CHIX:BIMP) Other Gross PPE : €97 Mil (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is BioMerieux Other Gross PPE?

BioMerieux's Other Gross PPE for the quarter that ended in Dec. 2024 was €97 Mil.

BioMerieux's quarterly Other Gross PPE declined from Dec. 2023 (€1,589 Mil) to Jun. 2024 (€-683 Mil) but then increased from Jun. 2024 (€-683 Mil) to Dec. 2024 (€97 Mil).

BioMerieux's annual Other Gross PPE increased from Dec. 2022 (€1,422 Mil) to Dec. 2023 (€1,589 Mil) but then declined from Dec. 2023 (€1,589 Mil) to Dec. 2024 (€97 Mil).


BioMerieux Other Gross PPE Historical Data

The historical data trend for BioMerieux's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMerieux Other Gross PPE Chart

BioMerieux Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,161.10 1,321.30 1,422.00 1,588.70 97.20

BioMerieux Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,422.00 1,503.30 1,588.70 -682.50 97.20

BioMerieux Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


BioMerieux Business Description

Traded in Other Exchanges
Address
Marcy l’Etoile, Lyon, FRA, 69280
BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (34% of 2023 sales), microbiology (39%), immunoassays (10%), and industrial applications (about 17%). The Amercas account for the largest portion of the firm's revenue (45%), followed by Europe, the Middle East, and Africa (31%), and Asia-Pacific (16%). BioMérieux is headquartered in Marcy-l'Etoile, France.

BioMerieux Headlines

No Headlines